In each of the five clusters, the primary hotspots are sorting out the biological properties, studying the molecular pathways, exploring the interaction between EGFR and KRAS, developing therapeutic strategies for colorectal cancer, and applying techniques to detect KRAS mutational status, respectively. The gene discussed is EGFR; the disease is colorectal cancer.